These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31846335)

  • 1. ICH M9 Guideline in Development on Biopharmaceutics Classification System-Based Biowaivers: An Industrial Perspective from the IQ Consortium.
    Bransford P; Cook J; Gupta M; Haertter S; He H; Ju R; Kanodia J; Lennernäs H; Lindley D; Polli JE; Wenning L; Wu Y
    Mol Pharm; 2020 Feb; 17(2):361-372. PubMed ID: 31846335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Permeability - Best Practices for Biopharmaceutics Classification System (BCS)-Based Biowaivers: A workshop Summary Report.
    Mehta M; Polli JE; Seo P; Bhoopathy S; Berginc K; Kristan K; Cook J; Dressman JB; Mandula H; Munshi U; Shanker R; Volpe DA; Gordon J; Veerasingham S; Welink J; Almeida S; Gonzalez P; Painter D; Tsang YC; Vaidyanathan J; Velagapudi R
    J Pharm Sci; 2023 Jul; 112(7):1749-1762. PubMed ID: 37142122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements.
    Davit BM; Kanfer I; Tsang YC; Cardot JM
    AAPS J; 2016 May; 18(3):612-8. PubMed ID: 26943914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries.
    Miranda C; Aceituno A; Fernández M; Mendes G; Rodríguez Y; Llauró V; Cabrera-Pérez MÁ
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33801796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Metformin Hydrochloride.
    Metry M; Shu Y; Abrahamsson B; Cristofoletti R; Dressman JB; Groot DW; Parr A; Langguth P; Shah VP; Tajiri T; Mehta MU; Polli JE
    J Pharm Sci; 2021 Apr; 110(4):1513-1526. PubMed ID: 33450218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Survey of the Regulatory Requirements for BCS-Based Biowaivers for Solid Oral Dosage Forms by Participating Regulators and Organisations of the International Generic Drug Regulators Programme.
    Van Oudtshoorn JE; García-Arieta A; Santos GML; Crane C; Rodrigues C; Simon C; Kim JM; Park SA; Okada Y; Kuribayashi R; Pfäffli C; Nolting A; Lojero IOC; Martínez ZR; Hung WY; Braddy AC; Leal NA; Triana DG; Clarke M; Bachmann P
    J Pharm Pharm Sci; 2018; 21(1):27-37. PubMed ID: 29382433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutics classification system: the scientific basis for biowaiver extensions.
    Yu LX; Amidon GL; Polli JE; Zhao H; Mehta MU; Conner DP; Shah VP; Lesko LJ; Chen ML; Lee VH; Hussain AS
    Pharm Res; 2002 Jul; 19(7):921-5. PubMed ID: 12180542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment for extending the Biopharmaceutics Classification System-based biowaiver of immediate release dosage forms of fluconazole in adults to the paediatric population.
    Charoo NA; Cristofoletti R; Dressman JB
    J Pharm Pharmacol; 2015 Aug; 67(8):1156-69. PubMed ID: 25828546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biowaiver monograph for immediate-release solid oral dosage forms: fluconazole.
    Charoo N; Cristofoletti R; Graham A; Lartey P; Abrahamsson B; Groot DW; Kopp S; Langguth P; Polli J; Shah VP; Dressman J
    J Pharm Sci; 2014 Dec; 103(12):3843-3858. PubMed ID: 25312492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Levetiracetam.
    Petruševska M; Berglez S; Krisch I; Legen I; Megušar K; Peternel L; Abrahamsson B; Cristofoletti R; Groot DW; Kopp S; Langguth P; Mehta M; Polli JE; Shah VP; Dressman J
    J Pharm Sci; 2015 Sep; 104(9):2676-87. PubMed ID: 25663270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
    Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
    J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Moxifloxacin Hydrochloride.
    Charoo NA; Abdallah DB; Parveen T; Abrahamsson B; Cristofoletti R; Groot DW; Langguth P; Parr A; Polli JE; Mehta M; Shah VP; Tajiri T; Dressman J
    J Pharm Sci; 2020 Sep; 109(9):2654-2675. PubMed ID: 32534881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commonality between BCS and TCS.
    Shah VP; Rădulescu FŞ; Miron DS; Yacobi A
    Int J Pharm; 2016 Jul; 509(1-2):35-40. PubMed ID: 27208656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biowaiver monographs for immediate release solid oral dosage forms: piroxicam.
    Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
    J Pharm Sci; 2014 Feb; 103(2):367-77. PubMed ID: 24301077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biowaiver Monograph for Immediate-Release Dosage Forms: Levamisole Hydrochloride.
    Kambayashi A; de Meijer M; Wegman K; van Veldhuizen C; Abrahamsson B; Cristofoletti R; Langguth P; Mehta M; Parr A; Polli JE; Shah VP; Dressman J
    J Pharm Sci; 2023 Mar; 112(3):634-639. PubMed ID: 36563854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Carbamazepine.
    García MA; Cristofoletti R; Abrahamsson B; Groot DW; Parr A; Polli JE; Mehta M; Shah VP; Tomakazu T; Dressman JB; Langguth P
    J Pharm Sci; 2021 May; 110(5):1935-1947. PubMed ID: 33610571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Excipient Risk in BCS Class I and III Biowaivers.
    Metry M; Polli JE
    AAPS J; 2022 Jan; 24(1):20. PubMed ID: 34988701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Cephalexin Monohydrate.
    Plöger GF; Quizon PM; Abrahamsson B; Cristofoletti R; Groot DW; Parr A; Langguth P; Polli JE; Shah VP; Tajiri T; Mehta MU; Dressman J
    J Pharm Sci; 2020 Jun; 109(6):1846-1862. PubMed ID: 32240696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution Profiles of Generic Products in Dissolution Media Defined by Japanese Guidelines for Bioequivalence Studies.
    Kajiwara E; Kamizato H; Shikano M
    Ther Innov Regul Sci; 2021 Sep; 55(5):1096-1100. PubMed ID: 34097289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.
    Parr A; Hidalgo IJ; Bode C; Brown W; Yazdanian M; Gonzalez MA; Sagawa K; Miller K; Jiang W; Stippler ES
    Pharm Res; 2016 Jan; 33(1):167-76. PubMed ID: 26286187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.